Do Local Reactions Predict Local Reactions With the Next Injection? Local reactions from immunotherapy are fairly common. They occur with a frequency of 26–82% among patients receiving AIT and in ...

Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...

The FDA has granted approval to a larger vial size of nelarabine injection (SH-111) for use in treatment of adult and ...

Please provide your email address to receive an email when new articles are posted on . 0.13% of subcutaneous immunotherapy injections led to systemic reactions. 15.8% of systemic reactions in SCIT ...

Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...

BEVERLY HILLS, Calif., Nov. 10, 2025 /PRNewswire/ -- Williams Cancer Institute ("WCI"), a leading center pioneering the use of intratumoral immunotherapy for late-stage cancer patients, announced that ...

Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

BOISE, ID, UNITED STATES, November 20, 2025 /EINPresswire.com/ -- In recent years, immunotherapy checkpoint inhibitors have transformed from an emerging scientific ...

Medications that target inflammation, such as immunotherapy and steroids, treat allergic asthma, a common type of asthma.

ORLANDO -- Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists' office. "I was pretty shocked the first time I used it ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...